Atlas Trials

Open Study of the Duration of Immunity After Vaccination With GamEvac

Clinical trial NCT02911428 · COMPLETED

Trial details

NCT number
NCT02911428
Sponsor
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation
Status
COMPLETED
Study type
OBSERVATIONAL
Hemorrhagic Fever, Ebola
Start date
2016-10-01
Primary completion
2017-12-25
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.